Ntv Asset Management LLC Merck & Co., Inc. Transaction History

Ntv Asset Management LLC

$807 Million
Q2 2025

A detailed history of Ntv Asset Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ntv Asset Management LLC holds 23,467 shares of MRK stock, worth $2.06 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

23,467

Previous 27,651 15.13%

Holding current value

$2.06 Million

Previous $2.48 Million 25.15%

% of portfolio

0.23%

Previous 0.34%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	SELL	$73.47 - $87.12 $307,398 - $364,510	-4,184 Reduced 15.13%	23,467 $1.86 Million
Q1 2025 Apr 30, 2025	SELL	$83.01 - $101.02 $1,079 - $1,313	-13 Reduced 0.05%	27,651 $2.48 Million
Q4 2024 Jan 31, 2025	SELL	$96.31 - $114.76 $60,193 - $71,725	-625 Reduced 2.21%	27,664 $2.75 Million
Q3 2024 Oct 31, 2024	SELL	$111.15 - $128.97 $37,235 - $43,204	-335 Reduced 1.17%	28,289 $3.21 Million
Q2 2024 Jul 31, 2024	BUY	$123.8 - $132.96 $142,370 - $152,904	1,150 Added 4.19%	28,624 $3.54 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $106,445 - $124,032	940 Added 3.54%	27,474 $3.63 Million
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $8,014 - $8,721	80 Added 0.3%	26,534 $2.89 Million
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $21,310 - $23,666	207 Added 0.79%	26,454 $2.72 Million
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $760 - $828	7 Added 0.03%	26,247 $3.03 Million
Q1 2023 May 05, 2023	SELL	$102.94 - $114.86 $153,689 - $171,485	-1,493 Reduced 5.38%	26,240 $2.79 Million
Q4 2022 Feb 08, 2023	SELL	$87.44 - $112.11 $16,788 - $21,525	-192 Reduced 0.69%	27,733 $3.08 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $15,215 - $17,092	-180 Reduced 0.64%	27,925 $2.41 Million
Q2 2022 Jul 28, 2022	BUY	$83.49 - $94.64 $4,925 - $5,583	59 Added 0.21%	28,105 $2.56 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $54,323 - $60,893	739 Added 2.71%	28,046 $2.3 Million
Q4 2021 Feb 04, 2022	SELL	$72.28 - $90.54 $7,372 - $9,235	-102 Reduced 0.37%	27,307 $2.09 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $172,318 - $189,507	2,404 Added 9.61%	27,409 $2.06 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $44,717 - $49,461	636 Added 2.61%	25,005 $1.95 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $42,211 - $49,720	-613 Reduced 2.45%	24,369 $1.88 Million
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $333,228 - $369,814	4,643 Added 22.83%	24,982 $2.04 Million
Q3 2020 Oct 29, 2020	BUY	$73.18 - $82.95 $22,466 - $25,465	307 Added 1.53%	20,339 $1.69 Million
Q2 2020 Aug 07, 2020	SELL	$70.42 - $80.13 $20,562 - $23,397	-292 Reduced 1.44%	20,032 $1.55 Million
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $89,654 - $124,265	1,415 Added 7.48%	20,324 $1.56 Million
Q4 2019 Jan 30, 2020	BUY	$77.58 - $87.54 $47,866 - $54,012	617 Added 3.37%	18,909 $1.72 Million
Q3 2019 Nov 04, 2019	BUY	$76.08 - $82.93 $29,747 - $32,425	391 Added 2.18%	18,292 $1.54 Million
Q2 2019 Jul 29, 2019	BUY	$69.84 - $81.59 $14,387 - $16,807	206 Added 1.16%	17,901 $1.5 Million
Q1 2019 Apr 29, 2019	BUY	$69.58 - $79.36 $487 - $555	7 Added 0.04%	17,695 $1.47 Million
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $101,709 - $118,031	-1,559 Reduced 8.1%	17,688 $1.35 Million
Q3 2018 Nov 08, 2018	SELL	$57.69 - $67.84 $16,903 - $19,877	-293 Reduced 1.5%	19,247 $1.37 Million
Q2 2018 Aug 06, 2018	SELL	$50.83 - $59.72 $88,291 - $103,733	-1,737 Reduced 8.16%	19,540 $1.19 Million
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $407 - $473	8 Added 0.04%	21,277 $1.16 Million
Q4 2017 Feb 06, 2018	BUY	$51.62 - $61.64 $309 - $369	6 Added 0.03%	21,269 $1.2 Million
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $410 - $441	7 Added 0.03%	21,263 $1.36 Million
Q2 2017 Aug 08, 2017	BUY	N/A	21,256	21,256 $1.36 Million

Others Institutions Holding MRK

# of Institutions

3,842

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $222B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.

Account

Ntv Asset Management LLC Merck & Co., Inc. Transaction History